Source:http://linkedlifedata.com/resource/pubmed/id/17172832
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
2006-12-25
|
pubmed:abstractText |
Expression of the viral protein R, Vpr, of HIV-1 affects many biological events in host cells including cell cycle progression, and modulates HIV-1 gene transcription. Earlier studies implicating the cellular protein p21(WAF1) (p21) in regulation of HIV-1 transcription, led us to investigate the functional and physical interaction of Vpr and p21. Our results show that Vpr modestly activated HIV-LTR in cells lacking p21 gene. Here, we describe the mechanisms by which p21 and Vpr leading to stimulation of HIV-1 transcription. Data from the protein-protein interaction experiments revealed the ability of Vpr, p21 and p300 to form a complex. Further, we show that, Vpr interacts with the N- and the C-terminal domains of p21. Furthermore, in cells expressing Vpr, p21 localizes to both the cytoplasm and the nucleus. Interestingly, expression of Vpr alleviates p21-mediated inhibition of cell departure from G1 phase. Expression of a mutant Vpr, with arginine 73 altered to serine, did not affect the ability of p21 to cause cells arrest or its sub-cellular localization. These observations reveal a new cellular partner for Vpr, and provide a new therapeutic avenue for controlling HIV-1 expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/E1A-Associated p300 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/EP300 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, vpr,
http://linkedlifedata.com/resource/pubmed/chemical/vpr Gene Products, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1551-4005
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2626-38
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17172832-Binding Sites,
pubmed-meshheading:17172832-Cell Cycle,
pubmed-meshheading:17172832-Cell Line, Tumor,
pubmed-meshheading:17172832-Cell Nucleus,
pubmed-meshheading:17172832-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:17172832-Cytoplasm,
pubmed-meshheading:17172832-E1A-Associated p300 Protein,
pubmed-meshheading:17172832-Gene Expression Regulation, Viral,
pubmed-meshheading:17172832-Gene Products, vpr,
pubmed-meshheading:17172832-HCT116 Cells,
pubmed-meshheading:17172832-HIV Long Terminal Repeat,
pubmed-meshheading:17172832-HIV-1,
pubmed-meshheading:17172832-Humans,
pubmed-meshheading:17172832-Microscopy, Fluorescence,
pubmed-meshheading:17172832-Models, Biological,
pubmed-meshheading:17172832-Transfection,
pubmed-meshheading:17172832-vpr Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2006
|
pubmed:articleTitle |
The role of Vpr in the regulation of HIV-1 gene expression.
|
pubmed:affiliation |
Department of Neuroscience & Center for Neurovirology, Temple University School of Medicine, Temple University, Philadelphia, Pennsylvania 19122, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|